Back

Low major bleeding, pump thrombosis and death rates in continuous flow left ventricular assist devices patients with good anticoagulation control.

27 August 2022 (10:15 - 10:55)
Organised by:
Congress Presentation Part of: Chronic heart failure - Left ventricular assist device Ventricular Assist Devices ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Eva Janssen

Leiden University Medical Center, Leiden (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Impact of right ventricular reserve on exercise capacity and quality of life in patients with left ventricular assist device
Doctor S. Takenaka (Sapporo, JP)
Abstract Slides
Presentation thumbnail
Impact of left ventricular ejection fraction on mortality and use of mechanical circulatory support in non-ischaemic cardiogenic shock
Mr J. Sundermeyer (Hamburg, DE)
Abstract Slides
Presentation thumbnail
Characteristics and outcomes of left ventricular assist device recipients transplanted before and after the new donor heart allocation system
Assistant Professor A. Briasoulis (Athens, GR)
Abstract Slides
Presentation thumbnail
Impact of preoperative hemodynamic optimization on right ventricular failure after left ventricular assist device implantation
Assistant Professor A. Briasoulis (Athens, GR)
Abstract Slides

Access the full session

Session thumbnail
Chronic heart failure - Left ventricular assist device

The Event

Event poster

ESC Congress 2022

27 August 2022 10:15 CET
You may be interested in
thumbnail
Congress Session
Devices in acute heart failure
thumbnail
Congress Session
Navigating through heart failure device therapies
thumbnail
Congress Session
Which device might help your HFpEF patient?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources